Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Infant Formula GI Tolerance Evaluation

NCT03307122 is registered in ClinicalTrials.gov with Société des Produits Nestlé (SPN) as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03307122 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Infant Formula GI Tolerance Evaluation
Lead sponsor
Société des Produits Nestlé (SPN)
Phase
Not applicable
Overall status
Completed
Start date
September 21, 2017
Completion date
January 19, 2018
Enrollment
79 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

healthy, full-term infants who are formula-fed